Sera Prognostics (SERA) Change in Accured Expenses (2020 - 2026)
Sera Prognostics posted quarterly Change in Accured Expenses of -$116000.0 for Q1 2026, up 76.42% year-on-year from -$65751.2 in Q1 2025, and down 115.41% on a QoQ basis from $753000.0 in Q4 2025.
Sera Prognostics (SERA) has 7 years of Change in Accured Expenses data on file, last reported at -$116000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 76.42% year-over-year to -$116000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 200.47% YoY), and the FY2025 full-year result was $682000.0, up 218.61% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$116000.0, down from $753000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $982000.0 in Q3 2022 and bottomed at -$1.9 million in Q1 2022.
- The 5-year median for Change in Accured Expenses is -$14000.0 (2024), against an average of -$166117.6.
- Peak annual rise in Change in Accured Expenses reached 1520.75% in 2025, while the deepest fall reached 3414.29% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $20000.0 in 2022, then plunged by 1690.0% to -$318000.0 in 2023, then soared by 83.33% to -$53000.0 in 2024, then surged by 1520.75% to $753000.0 in 2025, then sank by 115.41% to -$116000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$116000.0 (Q1 2026), $753000.0 (Q4 2025), and $16000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | -116,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116,000.00 |
| Mar 31, 2026 | -116,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 405,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Mar 31, 2025 | -492,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Sep 30, 2024 | -666,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -318,000.00 |
| Dec 31, 2023 | -318,000.00 |
| Sep 30, 2023 | -699,000.00 |
| Sep 30, 2023 | -699,000.00 |
| Jun 30, 2023 | 609,000.00 |
| Jun 30, 2023 | 609,000.00 |
| Mar 31, 2023 | -1.89 Mn |
| Mar 31, 2023 | -1.89 Mn |
| Dec 31, 2022 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 982,000.00 |
| Sep 30, 2022 | 982,000.00 |
| Jun 30, 2022 | 426,000.00 |
| Jun 30, 2022 | 426,000.00 |
| Mar 31, 2022 | -1.94 Mn |
| Mar 31, 2022 | -1.94 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 570,000.00 |
| Sep 30, 2021 | 570,000.00 |
| Jun 30, 2021 | 362,000.00 |
| Jun 30, 2021 | 362,000.00 |
| Mar 31, 2021 | -1.30 Mn |
| Mar 31, 2021 | -1.30 Mn |
| Dec 31, 2020 | 449,000.00 |
| Dec 31, 2020 | 449,000.00 |
| Sep 30, 2020 | 206,000.00 |
| Sep 30, 2020 | 206,000.00 |